JOUNCE THERAPEUTICS INC (JNCE) Stock Analyst Earnings Estimates
NASDAQ:JNCE - Nasdaq - US4811161011 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 62.3M -57.88% | 26.907M -56.81% | 82M 204.75% | -100.00% | 70.701M | 119.97M 69.69% | 199.8M 66.54% | 407.53M 103.97% | 492.14M 20.76% | 549.75M 11.71% | ||
| EBITDA YoY % growth | -41.7M -173.54% | -88.229M -111.58% | -50.155M 43.15% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -45.1M -185.42% | -91.056M -101.90% | -52.242M 42.63% | -152.16M -191.26% | -148.175M 2.62% | -90.484M 38.93% | -71.502M 20.98% | -25M 65.04% | 138.22M 652.88% | 198.57M 43.66% | 242.07M 21.91% | |
| Operating Margin | -72.39% | -338.41% | -63.71% | N/A | N/A | -127.98% | -59.60% | -12.51% | 33.92% | 40.35% | 44.03% | |
| EPS YoY % growth | -1.47 -190.18% | -1.84 -25.17% | -0.99 46.20% | -1.36 -37.55% | -1.05 22.85% | -1.26 -19.90% | -1.16 8.10% | -0.60 48.46% | 2.60 535.90% | 3.00 15.29% | 3.16 5.44% |
All data in USD
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.71 0.83% | -0.23 63.91% | -0.21 65.15% | -0.21 -121.34% | -0.27 62.86% | -0.27 -13.04% | -0.26 -21.95% | -0.26 -21.95% |
| Revenue Q2Q % growth | -100.00% | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -37.332M 0.35% | -12.75M 62.18% | -11.016M 64.92% | -11.07M -121.99% | -14.28M 61.75% | -14.28M -12.00% | -13.77M -25.00% | -13.77M -24.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 0.98 266.10% | -0.06 | 1.04 | 1,795.40% |
| Q3 2022 Q2Q % growth | -0.60 -1.69% | -0.65 | 0.05 | 7.85% |
| Q2 2022 Q2Q % growth | -0.65 -712.50% | -0.69 | 0.04 | 5.77% |
| Q1 2022 Q2Q % growth | -0.72 -24.14% | -0.59 | -0.13 | -22.76% |
| Q4 2021 Q2Q % growth | -0.59 -168.60% | -0.32 | -0.27 | -82.18% |
| Q3 2021 Q2Q % growth | -0.59 19.18% | -0.45 | -0.14 | -31.46% |
| Q2 2021 Q2Q % growth | -0.08 90.24% | -0.37 | 0.29 | 78.21% |
| Q1 2021 Q2Q % growth | -0.58 25.64% | -0.42 | -0.16 | -38.21% |
| Q4 2020 Q2Q % growth | 0.86 226.47% | 0.22 | 0.64 | 288.29% |
| Q3 2020 Q2Q % growth | -0.73 -125.17% | -0.48 | -0.25 | -50.90% |
| Q2 2020 Q2Q % growth | -0.82 -290.48% | -0.73 | -0.09 | -11.92% |
| Q1 2020 Q2Q % growth | -0.78 -105.26% | -0.58 | -0.20 | -34.16% |
| Q4 2019 Q2Q % growth | -0.68 | -0.29 | -0.39 | -135.30% |
| Q3 2019 Q2Q % growth | 2.90 | 2.28 | 0.62 | 26.93% |
| Q2 2019 Q2Q % growth | -0.21 | -0.29 | 0.08 | 26.47% |
| Q1 2019 Q2Q % growth | -0.38 | -0.31 | -0.07 | -24.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 82M | 41.82M | 40.18M | 96.08% |
| Q2 2022 Q2Q % growth | -100.00% | 212.497K | -212.497K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 692.141K | -692.141K | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 12.559M | -12.559M | -100.00% |
| Q3 2021 Q2Q % growth | 6.613M | -6.613M | -100.00% | |
| Q2 2021 Q2Q % growth | 25.368M | 8.34M | 17.028M | 204.17% |
| Q1 2021 Q2Q % growth | 1.5M | 12.043M | -10.543M | -87.54% |
| Q4 2020 Q2Q % growth | 62.3M | 40.056M | 22.244M | 55.53% |
| Q3 2020 Q2Q % growth | -100.00% | 3.035M | -3.035M | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | 1.7M | -1.7M | -100.00% |
| Q4 2019 Q2Q % growth | 15.3M | -15.3M | -100.00% | |
| Q3 2019 Q2Q % growth | 119.4M | 104.39M | 15.01M | 14.38% |
| Q2 2019 Q2Q % growth | 17.4M | 15.711M | 1.689M | 10.75% |
| Q1 2019 Q2Q % growth | 11M | 14.476M | -3.476M | -24.01% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -17.15% | 28.8% | 38.99% |
| Revenue | N/A | N/A | -100% | -100% |